TUG‘MA YURAK NUQSONLARINI KORREKSIYA QILGANDAN SO‘NG BOLALARDA INOTROP QO‘LLAB-QUVVATLASH PROFILI: DARAJASI, DOZASI VA DINAMIKASI
##article.subject##:
tug‘ma yurak nuqsonlari, MQT, O’VTAD, TF, inotrop terapiya, adrenalin, miomil, bolalar##article.abstract##
1 oylikdan 3 yoshgacha bo‘lgan 137 nafar bolada yurak tug‘ma nuqsonlari – magistral qon tomirlarining transpozitsiyasi (MQT), o‘pka venalarining to‘liq anormal drenaji (O’VTAD) va Fallo tetradasi (TF) kabi tug’ma yurak nuqsonlarini jarrohlik yo‘li bilan bartaraf etilgandan keyingi dastlabki 24 soat ichida inotrop preparatlarni qo‘llash chastotasi, dozalari va dinamikasi tahlil qilindi. Eng ko‘p qo‘llanilgan dori vositalari adrenalin va miomil bo‘lib, ular asosan dastlabki 6 soatda buyurilgan va 24-soatga kelib ularning qo‘llanilishi kamaygan. Yurak nuqsoni turiga qarab inotrop qo‘llab-quvvatlashda farqlar aniqlandi. Natijalar terapiyani optimallashtirish va erta operatsiyadan keyingi davrda protokollarni ishlab chiqishda asos bo‘lishi mumkin.
Библиографические ссылки
Bouma B.J., Mulder B.J.M. Global burden of congenital heart disease // Lancet. – 2017. – Vol. 390. – P. 2012–2013.
Karamlou T., Kotani Y., Maeda K. et al. Postoperative complications in pediatric cardiac surgery // J. Thorac. Cardiovasc. Surg. – 2021. – Vol. 161(2). – P. 640–647.
Lasa J.J., Bembea M.M., Amin P. et al. Hemodynamic support in pediatric intensive care: consensus guidelines from ESPNIC // Intensive Care Med. – 2022. – Vol. 48. – P. 76–93.
Hanot J., Wolfler A., Biran V. et al. Practice variation in fluid and inotrope therapy in Europe // Pediatr. Crit. Care Med. – 2019. – Vol. 20(4). – P. e173–e180.
McGowan F.X., Todorov A. Early postoperative management in congenital heart disease // Curr. Opin. Anesthesiol. – 2023. – Vol. 36(1). – P. 49–55.
Andropoulos D.B., Dunbar-Masterson C. Outcomes after congenital cardiac surgery in neonates // Anesth. Analg. – 2020. – Vol. 130(1). – P. 135–146.
Macrae D.J., Van der Linden J., Brown K.L. Pediatric perfusion practices in Europe: results from a survey // Intensive Care Med. – 2019. – Vol. 45. – P. 132–139.
Park K., Han S.Y., Ahn H. Fluid management after pediatric cardiac surgery // J. Cardiothorac. Vasc. Anesth. – 2022. – Vol. 36(3). – P. 723–729.
He Y., Jin J., Gu W. Inotrope and vasopressor variability after CHD correction // J. Pediatr. – 2021. – Vol. 230. – P. 182–189.
Singer M., Deutschman C.S., Seymour C.W. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) // Crit. Care Med. – 2021. – Vol. 45(3). – P. 486–512.
Beardsall K., Dunger D.B., Ogunbona O. Pediatric critical care in congenital cardiac conditions // Front. Pediatr. – 2023. – Vol. 11. – Article 1112543.
GBD 2017 Congenital Heart Disease Collaborators. Global analysis of congenital anomalies // Lancet. – 2018. – Vol. 392. – P. 10159–10205.
